BWB759U, AN ANALOGUE OF ACYCLOVIR, INHIBITS HUMAN CYTOMEGALOVIRUS IN VITRO
- 20 October 1984
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 324 (8408), 924-925
- https://doi.org/10.1016/s0140-6736(84)90677-9
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitroAntimicrobial Agents and Chemotherapy, 1983
- PROPHYLAXIS OF HERPES INFECTIONS AFTER BONE-MARROW TRANSPLANTATION BY ORAL ACYCLOVIRThe Lancet, 1983
- Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1.Proceedings of the National Academy of Sciences, 1983
- Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanineAntimicrobial Agents and Chemotherapy, 1983
- Nonbacterial Pneumonia After Allogeneic Marrow Transplantation: A Review of Ten Years' ExperienceClinical Infectious Diseases, 1982
- Maternal Cytomegalovirus Infection and Perinatal TransmissionClinical Obstetrics and Gynecology, 1982
- In vitro and in vivo responses of cytomegalovirus to acyclovirAmerican Journal Of Medicine, 1982
- Treatment of cytomegalovirus pneumonia with high-dose acyclovirAmerican Journal Of Medicine, 1982
- Acyclovir in immunocompromised patients with cytomegalovirus disease: A controlled trial at one institutionAmerican Journal Of Medicine, 1982
- The in vitro activity of Acyclovir and related compounds against cytomegalovirus infectionsJournal of Antimicrobial Chemotherapy, 1981